Study design and clinical evidence in mRCC: can we save axitinib as a first-line therapy?

Missing/wrong data? Edit Wikidata item

Study design and clinical evidence in mRCC: can we save axitinib as a first-line therapy?

scientific article

Author/s

Wikidata

Work details

Publication date: February 20, 2014

Copyright status

Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.

To learn more about copyright terms in different countries, visit the countries and terms page.